Halozyme Therapeutics
HALO
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
YETI Holdings
YETI
4
eBay
EBAY
5
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -55.97%52.32M | -55.97%52.32M | -59.75%55.99M | -63.70%56.46M | -55.24%81.01M | -48.37%118.82M | -48.37%118.82M | -36.44%139.1M | -36.03%155.54M | -33.18%181M |
-Cash and cash equivalents | -44.89%37.02M | -44.89%37.02M | -53.79%46.03M | -77.05%35.7M | -75.36%44.6M | -70.77%67.16M | -70.77%67.16M | -54.41%99.62M | -35.91%155.54M | -33.18%181M |
-Short-term investments | -70.38%15.3M | -70.38%15.3M | -74.78%9.96M | --20.76M | --36.42M | 15,228.19%51.66M | 15,228.19%51.66M | 11,513.82%39.49M | ---- | ---- |
Receivables | 27.23%29.19M | 27.23%29.19M | 6.27%35.55M | 2.67%38.12M | -7.01%24.57M | -34.02%22.94M | -34.02%22.94M | 26.29%33.45M | 143.39%37.13M | 163.24%26.42M |
-Accounts receivable | 31.77%28.39M | 31.77%28.39M | 17.02%34.86M | 12.46%36.43M | -4.86%22.03M | -32.50%21.55M | -32.50%21.55M | 40.51%29.79M | 165.89%32.39M | 169.60%23.16M |
-Other receivables | -42.81%799K | -42.81%799K | -81.02%696K | -64.29%1.69M | -22.27%2.54M | -51.02%1.4M | -51.02%1.4M | -30.69%3.67M | 54.14%4.73M | 125.48%3.27M |
Inventory | 63.99%16.96M | 63.99%16.96M | 107.97%16.28M | 269.71%18.6M | 24.85%11.01M | 0.85%10.34M | 0.85%10.34M | 16.25%7.83M | -16.27%5.03M | 22.77%8.82M |
Prepaid assets | 3.82%15.84M | 3.82%15.84M | ---- | ---- | ---- | 17.90%15.25M | 17.90%15.25M | ---- | ---- | ---- |
Restricted cash | --0 | --0 | -72.50%275K | --0 | --0 | --275K | --275K | 150.00%1M | 150.00%1M | 150.00%1M |
Other current assets | 24.70%7.14M | 24.70%7.14M | 28.90%26.31M | 41.62%24.72M | 42.42%25.22M | 27.26%5.72M | 27.26%5.72M | 474.06%20.41M | 432.68%17.46M | 490.20%17.71M |
Total current assets | -29.94%121.45M | -29.94%121.45M | -33.40%134.4M | -36.20%137.9M | -39.64%141.8M | -40.75%173.36M | -40.75%173.36M | -26.56%201.79M | -24.78%216.15M | -23.53%234.94M |
Non current assets | ||||||||||
Net PPE | 20.37%137.65M | 20.37%137.65M | 41.46%135.14M | 48.44%122.21M | 115.32%131.88M | 146.56%114.36M | 146.56%114.36M | 125.24%95.53M | 125.73%82.33M | 122.16%61.25M |
-Gross PPE | 30.22%171.05M | 30.22%171.05M | 48.88%163.22M | 55.72%146.41M | 114.93%152.11M | 142.50%131.35M | 142.50%131.35M | 124.10%109.64M | 123.59%94.02M | 121.14%70.77M |
-Accumulated depreciation | -96.49%-33.4M | -96.49%-33.4M | -99.11%-28.08M | -106.98%-24.2M | -112.43%-20.23M | -118.29%-17M | -118.29%-17M | -116.70%-14.1M | -109.63%-11.69M | -114.77%-9.53M |
Non current accounts receivable | -31.85%657K | -31.85%657K | 35.48%672K | -79.13%144K | -57.06%307K | -30.45%964K | -30.45%964K | -67.45%496K | -78.16%690K | -78.47%715K |
Other non current assets | -1.76%8.3M | -1.76%8.3M | -4.53%8.25M | -6.07%8.27M | -4.13%8.27M | 8.83%8.45M | 8.83%8.45M | 24.82%8.65M | 44.98%8.8M | 49.08%8.63M |
Total non current assets | 18.46%146.61M | 18.46%146.61M | 37.63%144.07M | 42.26%130.62M | 98.97%140.46M | 122.89%123.77M | 122.89%123.77M | 105.79%104.67M | 100.91%91.82M | 92.46%70.59M |
Total assets | -9.78%268.06M | -9.78%268.06M | -9.14%278.47M | -12.81%268.52M | -7.62%282.26M | -14.65%297.13M | -14.65%297.13M | -5.88%306.47M | -7.53%307.97M | -11.16%305.53M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -39.08%11.6M | -39.08%11.6M | -37.93%8.62M | -67.04%5.57M | -18.80%15.58M | -4.18%19.04M | -4.18%19.04M | 3.53%13.89M | 49.65%16.91M | 203.19%19.19M |
-accounts payable | -39.70%10.49M | -39.70%10.49M | -37.93%8.62M | -67.04%5.57M | -18.80%15.58M | -4.36%17.4M | -4.36%17.4M | 24.67%13.89M | 79.40%16.91M | 313.18%19.19M |
-Total tax payable | -32.50%1.11M | -32.50%1.11M | ---- | ---- | ---- | -2.20%1.64M | -2.20%1.64M | ---- | ---- | ---- |
Current accrued expenses | 96.20%5.67M | 96.20%5.67M | 39.89%17.02M | 47.06%15.91M | 111.70%13.71M | 300.55%2.89M | 300.55%2.89M | 1,103.17%12.16M | 387.43%10.82M | 100.22%6.48M |
Current debt and capital lease obligation | 58.38%2.2M | 58.38%2.2M | 32.39%2.19M | 55.22%1.75M | 52.67%1.71M | -87.48%1.39M | -87.48%1.39M | -67.59%1.66M | -77.83%1.13M | -72.56%1.12M |
-Current capital lease obligation | 58.38%2.2M | 58.38%2.2M | 32.39%2.19M | 55.22%1.75M | 52.67%1.71M | 24.87%1.39M | 24.87%1.39M | 49.64%1.66M | 3.01%1.13M | 3.03%1.12M |
Current deferred liabilities | 37.81%64.51M | 37.81%64.51M | 16.23%61.65M | 42.68%56.17M | 104.00%48.91M | 156.16%46.81M | 156.16%46.81M | 234.60%53.04M | 265.11%39.37M | 222.58%23.98M |
Other current liabilities | 118.21%7.39M | 118.21%7.39M | ---- | ---- | ---- | 76.64%3.39M | 76.64%3.39M | ---- | ---- | ---- |
Current liabilities | 18.95%96.71M | 18.95%96.71M | 10.81%89.48M | 16.39%79.41M | 57.43%79.92M | 37.51%81.3M | 37.51%81.3M | 97.04%80.75M | 106.35%68.23M | 118.03%50.77M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | --12.33M | --12.33M | 9,202.26%12.37M | 55.92%566K | 55.56%980K | --0 | --0 | -97.82%133K | -95.06%363K | -92.66%630K |
-Long term capital lease obligation | --12.33M | --12.33M | 9,202.26%12.37M | 55.92%566K | 55.56%980K | --0 | --0 | -88.40%133K | -74.03%363K | -61.44%630K |
Non current deferred liabilities | -19.42%20.27M | -19.42%20.27M | 22.53%23.87M | 14.19%23.66M | 9.93%22.81M | 42.12%25.15M | 42.12%25.15M | 110.94%19.48M | 378.41%20.72M | 359.33%20.75M |
Derivative product liabilities | -60.54%4.3M | -60.54%4.3M | -52.67%5.43M | -80.37%3.85M | 10.97%8.74M | 77.81%10.89M | 77.81%10.89M | 70.34%11.47M | 251.26%19.63M | 44.64%7.87M |
Other non current liabilities | -52.85%16.81M | -52.85%16.81M | -52.39%18.34M | -85.49%7.96M | 30.24%28.22M | 102.44%35.65M | 102.44%35.65M | 171.54%38.52M | 143.76%54.88M | -1.14%21.67M |
Total non current liabilities | -25.09%53.7M | -25.09%53.7M | -13.79%60.01M | -62.30%36.04M | 19.30%60.75M | 15.62%71.69M | 15.62%71.69M | 91.96%69.6M | 140.26%95.58M | 25.84%50.92M |
Total liabilities | -1.69%150.41M | -1.69%150.41M | -0.58%149.48M | -29.53%115.44M | 38.33%140.67M | 26.30%152.99M | 26.30%152.99M | 94.65%150.35M | 124.87%163.81M | 59.51%101.69M |
Shareholders'equity | ||||||||||
Share capital | 6.67%16K | 6.67%16K | 6.67%16K | 6.67%16K | 6.67%16K | 0.00%15K | 0.00%15K | 7.14%15K | 7.14%15K | 7.14%15K |
-common stock | 6.67%16K | 6.67%16K | 6.67%16K | 6.67%16K | 6.67%16K | 0.00%15K | 0.00%15K | 7.14%15K | 7.14%15K | 7.14%15K |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | -17.97%-354.66M | -17.97%-354.66M | -20.37%-338.94M | -6.63%-306.65M | -40.44%-310.11M | -56.42%-300.65M | -56.42%-300.65M | -71.79%-281.57M | -97.93%-287.57M | -85.11%-220.82M |
Paid-in capital | 6.18%472.33M | 6.18%472.33M | 6.94%468.04M | 6.48%459.75M | 6.37%451.73M | 6.12%444.83M | 6.12%444.83M | 6.17%437.68M | 6.48%431.76M | 6.32%424.67M |
Gains losses not affecting retained earnings | 39.62%-32K | 39.62%-32K | -1,322.22%-128K | 2.33%-42K | -92.31%-50K | -430.00%-53K | -430.00%-53K | -125.71%-9K | -330.00%-43K | ---26K |
Total stockholders'equity | -18.38%117.65M | -18.38%117.65M | -17.38%128.99M | 6.18%153.07M | -30.54%141.59M | -36.50%144.14M | -36.50%144.14M | -37.15%156.12M | -44.60%144.16M | -27.24%203.84M |
Total equity | -18.38%117.65M | -18.38%117.65M | -17.38%128.99M | 6.18%153.07M | -30.54%141.59M | -36.50%144.14M | -36.50%144.14M | -37.15%156.12M | -44.60%144.16M | -27.24%203.84M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |